Please ensure Javascript is enabled for purposes of website accessibility

FDA letting troubled COVID vaccine factory in Baltimore restart (access required)

The FDA is allowing the problem-plagued Baltimore factory of Emergent BioSolutions to resume production of the Johnson & Johnson COVID-19 vaccine.